Updated on 17 August 2012
Figure (below): The process of molecular pharming
Wuhan Healthgen Biotech used the technology of molecular pharming to successfully produce recombinant Human Serum Albumin (OsrHSA), recombinant alpha-1 antitrypsin (OsrAAT), recombinant acidic fibroblast growth factor (OsraFGF) and recombinant basic fibroblast growth factor (OsrbFGF). The expression level ranges from 20-to-150μg per grain. Healthgen biotechnology will willingly provide the competitive products and expression platform services to all its customers.